Invention Grant
US07829737B2 Protein tyrosine phosphatase inhibitors and methods of use thereof 有权
蛋白酪氨酸磷酸酶抑制剂及其使用方法

Protein tyrosine phosphatase inhibitors and methods of use thereof
Abstract:
The present invention provides compounds of Formula (I) and Formula (II) that are useful for modulating the biological activity of the protein tyrosine phosphatase-1b (PTP1B) enzyme. Compounds of this invention can be used to treat diseases and/or conditions in which the PTP1B enzyme is a factor. Such diseases and/or conditions include, but are not limited to, Type 1 diabetes, Type 2 diabetes, inadequate glucose tolerance, insulin resistance, obesity, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, low HDL levels, atherosclerosis, vascular restenosis, inflammatory bowel disease, pancreatitis, adipose cell tumors, adipose cell carcinoma, liposarcoma, dyslipidemia, cancer, and neurodegenerative diseases.
Public/Granted literature
Information query
Patent Agency Ranking
0/0